Vivek Mani has over a decade of experience leading teams and consulting to clients on regulatory and litigation issues involving competition. His expertise includes collective actions, cartels, and mergers in Europe and the United States. Mr. Mani’s competition experience covers a range of industries, including automobiles, financial institutions, pharmaceuticals, retail, technology, and telecommunications. Lexology Index (formerly Who’s Who Legal) named Mr. Mani a Future Leader among economists in the global competition field and has since recommended him as a leading competition economist and consulting expert.
Competition
Mr. Mani consults to clients on class certification/collective action issues in antitrust matters in U.S. and UK. He has particular experience analyzing class certification issues in technology and financial markets, where he has conducted empirical analyses of large proprietary datasets in the context of price fixing allegations.
In financial markets, Mr. Mani has analyzed price fixing allegations related to asset and benchmark prices, as well as bid-ask spreads for financial instruments across various trading platforms.
Pharmaceuticals
Mr. Mani has consulted to pharmaceutical clients on numerous matters, including breach of contract, antitrust, product misrepresentation, and securities and intellectual property. He has addressed issues related to alleged trade secrets and drug development, drug pricing and reimbursement, brand-to-brand competition, generic competition, and damages.
Mr. Mani has testified at an arbitration hearing on damages issues in a life sciences matter.
Merger reviews
Mr. Mani leads merger review teams for the merging parties in the U.S. and Europe. He has assessed horizontal and vertical issues arising in a range of industries, including industrial goods, retail, technology, and telecommunications. Mr. Mani has experience with matters involving sampling and survey design, and in conducting and critiquing surveys as part of Phase I merger investigations, as in a European Commission (EC) review of a proposed cloud technology company merger. He has also worked on Phase II merger inquiries in Europe, as in the EC’s Phase II Investigation of the Essilor/Luxottica merger.
Additional merger experience includes:
- Alaska Airlines/Hawaiian Airlines
- Meta/Kustomer
- EssilorLuxottica’s Acquisition of GrandVision
- Selecta’s Acquisition of Pelican Rouge
On both sides of the Atlantic, Mr. Mani publishes and speaks extensively on topics related to class certification and collective actions, economic issues in the pharmaceutical industry, and merger analyses.
Mr. Mani has served as a member of Cornerstone Research’s Diversity, Equity, and Inclusion (DEI) Council.
Expert Forum: Frontline Perspectives on Recent Developments in Competition Litigation, AI and Mergers
Expert Forum: Frontline Perspectives on Recent Developments in Antitrust Litigation, Privacy and Mergers
Cornerstone Research Once Again Named “Go-To Thought Leader” by National Law Review
- Alaska Airlines/Hawaiian Airlines Merger
- EC Investigation into Cloud Technology Company Merger
- EssilorLuxottica’s Acquisition of GrandVision
- Meta/Kustomer Merger
- ICC Arbitration Involving Commercially Reasonable Efforts to Develop and Commercialize a Drug
- EC’s Phase II Investigation of Essilor/Luxottica Merger
- Selecta’s Acquisition of Pelican Rouge
- Alleged Theft of Trade Secrets for a Drug in Development
|
|